No Detail Found!

Dexmedetomidine Infusion for Sedation of a Patient with Multiple System Atrophy during Spinal Anesthesia.

Author(s)
Satoko Kinouchi Department of Anesthesiology, Minoh City Hospital, 5-7-1 Kayano, Mino-shi, Osaka, Japan
Yoshie Onishi Department of Anesthesiology, Minoh City Hospital, 5-7-1 Kayano, Mino-shi, Osaka, Japan
Luna Nishihara Department of Anesthesiology, Minoh City Hospital, 5-7-1 Kayano, Mino-shi, Osaka, Japan
Toshiki Okada Department of Anesthesiology, Minoh City Hospital, 5-7-1 Kayano, Mino-shi, Osaka, Japan
Abstract
Multiple system atrophy (MSA) is a progressive neurodegenerative disorder characterized by extra-pyramidal symptoms, cerebellar ataxia, and autonomic dysfunction. The perioperative management of patients with MSA is challenging primarily due to autonomic dysfunction and vocal cord paralysis. Dexmedetomidine (DEX) is a highly selective a2-adrenoreceptor agonist that is used as a sedative, causing minimal depression of the respiratory function. We administered DEX continuously for sedation during spinal anesthesia for bipolar hip arthroplasty in a patient with MSA, without any cardiovascular or respiratory complications. This is the first case report of the efficacy of DEX for the sedation of a patient with MSA during spinal anesthesia.
Publication Details
Page(s) 122-124
DOI DOI not available
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 22, Issue: 1, Year: 2018

Request the full text from PASTIC

References
atrophy.Neurology, 2008., 71 670 -
., 10 -
.,w n l . 0 0 0 0 3 2 4 6 2 5 . 0 0 4 0 4 . 1 5 -
LancetNeurol, 2004., 3 93 -103
.,doi:10 4422 00662 -
., -
Psychiatry, 1996., 60 399 -402
2002.,Head Neck Surg 128 1404 -
., -
1994., 10 484 -486
., -
2007.system atrophy as a cause of upper airway obstruction,Anaesthesia. 2 0 05227 2044 -
McNicholasWT,RutherfordR,GrossmanR,MoldofskyH,ZamelN,PhillipsonEA, 1983.Abnormal respiratory pattern generation during sleep in patients with autonomic dysfunction,Am Rev Respir Dis 128 429 -433
SweeneyBP,JonesS,LangtordRM, 1985.Anaesthesia in dysautonomia: further complications,Anaesthesia 40 783 -786
HanningCD, 1989.Obstructive sleep'apnoea,Br J Aneasth 63 477 -488
Scott-WarrenVL,SebastianJ,Dexmedetomidine, 2016.: its use in intensive care medicine and anaesthesia,BJA Education 16 242 -246
KluyskensY,BossaertL,SnoeckJ,MartinJJ, 1977.Idiopathic orthostatic hypotension and the Shy and Drager syndrome: physiological studies in four cases-pathological report of one case,Acta Cardiol 32 317 -335
BevanDR, 1979.Shy-Drager syndrome: a review and a description of the anaesthetic management,Anaesthesia 34 866 -873
BannisterR, 1979.Chronic autonomic failure with postural hypotension,Lancet 2 404 -406
StirtJA,FrantzRA,GunzEF,ConollyME, 1982.Anesthesia, catecholamines, and hemodynamics in autonomic dysfunction,Anesth Analg 61 701 -704
1971.Anesthetic management of a patient with the Shy-Drager Syndrome,Anesthesiology 35 95 -97
LakhlaniPP,MacMillanLB,GuoTZ,McCoolBA,LovingerDM,MazeM, 1997.Substitution of a mutant α2Aadrenergic receptor via 'hit and run' gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo,Proc Natl Acad Sci U S A 94 9950 -9955
KamibayashiT,MazeM., 2000.Clinical uses of α2-Adrenergic Agonists, 93 1345 -1349
AbulhasanY,BuuN,FrigonC, 2009.Perioperative use of dexmedetomidine in an infant with familial dysautonomia,BJA 10 413 -415
0

Citations

0

Downloads

110

Views